课题基金 / 基金详情

PADI4-Cit - Precision bifunctional peptide tools to understand protein citrullination

PADI4-Cit - Precision bifunctional peptide tools to understand protein citrullination
PADI4-Cit - 用于了解蛋白质瓜氨酸化的精密双功能肽工具
批准号:
EP/Y029704/1
负责人:
Huawu Yin
金额:
$25.55万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Protein citrullination is a posttranslational modification (PTM) involved in a wide range of biological functions including epigeneticgene regulation and the innate immune response. Its dysregulation is implicated in the progress of diverse pathogeneses. Despitethese important roles, our understanding of citrullination remains in its infancy. Citrullination in mammals is catalysed by fivepromiscuous isozymes from the peptidylarginine deiminase (PADI) family, which display overlapping substrate specificities and arange of tissue expression patterns. This complex landscape makes precise understanding of the effects of citrullination challenging,with no general strategies currently available to explore citrullination at the single substrate level. To dissect this complicated system,I aim to develop bifunctional chemical tools to recruit PADI enzymes to specific substrates and genes, allowing investigation of theeffects of citrullination on protein function and gene expression with a level of precision and specificity not currently possible. I willfocus on PADI4, the primarily nuclear member of the PADIs, producing methods to precisely understand the biochemical effects ofsingle citrullination events in a cell-based context at the substrate level. My new bifunctional tools will be used to address two relatedgoals: understanding the effect of citrullination on 1) individual protein substrates, and 2) gene regulation. Results from this workshould shed light on this relatively poorly understood PTM, providing new insight into the effects of citrullination on protein functionand a blueprint for future applications to study other substrates and PADIs, with the potential to provide new avenues for therapeuticintervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于MLKL/PAD4/H3Cit通路探讨双参颗粒调控NETs逆转CD8+T细胞耗竭抑制肺非典型腺瘤样增生恶性进展的机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    胡佳奇
  • 依托单位:
TPO-RA类药物海曲泊帕在淋巴瘤CIT防治中的作用及机制的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
基于 MLKL/PAD4/H3Cit通路探讨双参颗粒调控NETs逆转CD8+细胞耗绳抑制肺非典型腺瘤样增生恶性进展的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    胡佳奇
  • 依托单位:
CIT基因作为西妥昔协同作用靶标对结直肠癌发生发展的作用机制研究
  • 批准号:
    81301950
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    朱向莹
  • 依托单位: